Smiths Medical today issued an urgent medical device correction letter to inform customers of potential issues with its CADD infusion system.
The company — which ICU Medical acquired in January for $2.35 billion — identified two potential issues with the infusion sets. They relate to the potential lack of delivery or underdelivery and false no disposable attached (NDA) alarms.
Get the full story at our sister site, Drug Delivery Business News.